Top
B4GALT2 has not been detected as a mutational cancer driver

B4GALT2
Ensembl id ENSG00000117411
Mutated samples
Coding Sequence 58 (0.9%)
Protein Affecting 16 (0.2%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all B4GALT2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Uterine corpus endometrioid carcinoma No 8 4 1.74
Stomach adenocarcinoma No 5 3 1.86
Cutaneous melanoma No 11 2 0.54
Head and neck squamous cell carcinoma No 6 2 0.53
Prostate adenocarcinoma No 2 1 0.41
Lung adenocarcinoma No 4 1 0.26
Serous ovarian adenocarcinoma No 1 1 0.32
Small cell lung carcinoma No 1 1 1.45
Glioblastoma multiforme No 1 1 0.26
Hepatocarcinoma No 2 0 0.00
Bladder carcinoma No 4 0 0.00
Acute myeloid leukemia No 1 0 0.00
Breast carcinoma No 6 0 0.00
Lung squamous cell carcinoma No 1 0 0.00
Renal clear cell carcinoma No 2 0 0.00
Thyroid carcinoma No 1 0 0.00
Esophageal carcinoma No 2 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence